Report Categories
View AllRecent Articles
View All
INO Inovio Pharmaceuticals beats Q4 2025 earnings estimates by wide margin shares gain 132 percent today
Why Verastem VSTM might be early to something big Market Focus 20260506
CRBP Corbus posts narrower than expected Q4 2025 loss yet shares dip 157 percent in todays trading
How Select SEM revenue breaks down and what it means Flatline 20260508